Publications by authors named "Maja Beus"

This study focuses on the modulatory effects of gold nanoclusters with 25 gold atoms and 18 acetyl cysteines (AuAcCys) in human microglia, human iPSC-derived neurons and SH-SY5Y differentiated human neuronal cells. The combination of chemical, biological, and computational methods shows the well-retained viability of these human cells treated with AuAcCys, interactions between AuAcCys and transcription factor TFEB (computational approach), interactions between TFEB and HMGB1 (proximity ligation assay and molecular modeling using AlphaFold), modulation of the abundance and location of acHMGB1 by AuAcCys (immunocytochemistry), and the reduction of ROS in cells treated with AuAcCys (CellROX live imaging). These novel findings in human neural cells, particularly neurons, encourage further studies in experimental animal models of neurological disorders and/or human organoids to exploit the unique structural and photophysical properties of gold nanoclusters and to better understand their ability to modulate molecular mechanisms in human cells.

View Article and Find Full Text PDF

Nanotechnology has the potential to provide formulations of antitumor agents with increased selectivity towards cancer tissue thereby decreasing systemic toxicity. This study evaluated the potential of novel nanoformulation based on poly(lactic--glycolic acid) (PLGA) to reduce the cardiotoxic potential of doxorubicin (DOX). toxicity of PLGADOX was compared with clinically approved non-PEGylated, liposomal nanoformulation of DOX (LipoDOX) and conventional DOX form (ConvDOX).

View Article and Find Full Text PDF

Inhibiting quorum sensing (QS), a central communication system, is a promising strategy to combat bacterial pathogens without antibiotics. Here, we designed novel hybrid compounds targeting the PQS ( quinolone signal)-dependent quorum sensing (QS) of that is one of the multidrug-resistant and highly virulent pathogens with urgent need of new antibacterial strategies. We synthesized 12 compounds using standard procedures to combine halogen-substituted anthranilic acids with 4-(2-aminoethyl/4-aminobuthyl)amino-7-chloroquinoline, linked via 1,3,4-oxadiazole.

View Article and Find Full Text PDF
Article Synopsis
  • Silver nanoparticles (AgNPs) exhibit antimicrobial properties and have various applications, but their toxicity after long-term exposure is still a concern.
  • The study found that different surface coatings of AgNPs influence in vitro toxicity and internalization in porcine kidney (PK15) cells, with toxicity levels varying based on the coating used.
  • All AgNPs induced the creation of reactive oxygen species and decreased the cell's antioxidant levels, raising potential genotoxicity risks at concentrations as low as 2 mg Ag/L, highlighting the need for biosafety assessments in developing AgNP-based materials.
View Article and Find Full Text PDF

In the present study, we report the design and synthesis of novel amide-type hybrid molecules based on anthranilic acid and quinoline or β-carboline heterocyclic scaffolds. Three types of biological screenings were performed: (i) in vitro antiproliferative screening against a panel of solid tumor and leukemia cell lines, (ii) antiviral screening against several RNA viruses, and (iii) anti-quorum sensing screening using gram-negative Chromobacterium violaceum as the reporter strain. Antiproliferative screening revealed a high activity of several compounds.

View Article and Find Full Text PDF

As cancer remains one of the major health burdens worldwide, novel agents, due to the development of resistance, are needed. In this work, we designed and synthesized harmirins, which are hybrid compounds comprising harmine and coumarin scaffolds, evaluated their antiproliferative activity, and conducted cell localization and cell cycle analysis experiments. Harmirins were prepared from the corresponding alkynes and azides under mild reaction conditions using Cu(I) catalyzed azide-alkyne cycloaddition, leading to the formation of the 1-1,2,3-triazole ring.

View Article and Find Full Text PDF

Drug safety assessment in the early phases of drug discovery is critical to facilitate the rapid development of novel therapeutics. Recently, teleost zebrafish (Danio rerio) has emerged as a promising vertebrate model for the assessment of drug safety. Zebrafish is a convenient model because of its small size, high fecundity, embryo transparency, and ex utero development.

View Article and Find Full Text PDF

In this paper, we report the synthesis of novel hybrids 2-14 based on itaconic acid and fluoroaniline, pyridine, indole and quinoline scaffolds. Itaconic acid is a naturally occurring compound with a Michael acceptor moiety, a key structural feature in several anticancer and antiviral drugs, responsible for the covalent binding of a drug to the cysteine residue of a specific protein. Aromatic parts of the hybrids also come from the substances reported as anticancer or antiviral agents.

View Article and Find Full Text PDF

Quorum sensing inhibitors (QSIs) that specifically interfere with bacterial cell-to-cell communication are considered as an alternative approach to conventional antibacterial therapy. In our study, a set of twenty-six fumardiamides with a quinoline head-group were evaluated as potential QSIs. Two strains of Gram-negative Chromobacterium violaceum (violacein-producing strain ATCC31532 and violacein-negative, mini-Tn5 mutant derivative CV026) were used as QS reporters for testing anti-QS and bactericidal activity of various quinoline fumardiamides.

View Article and Find Full Text PDF
Article Synopsis
  • The text discusses modifications of primaquine, a well-known antimalarial drug, aiming to improve its bioavailability, reduce toxicity, and extend its effectiveness.
  • Modifications focused on the quinoline ring and amino groups to avoid the creation of inactive toxic metabolites and repurpose compounds for different activities.
  • The review highlights various classes of primaquine N-derivatives developed in the last decade, summarizing their synthesis and assessing their potential for creating new antiplasmodial, anticancer, antimycobacterial, and antibiofilm agents.
View Article and Find Full Text PDF

This paper describes a continuation of our efforts in the pursuit of novel antiplasmodial agents with optimized properties. Following our previous discovery of biologically potent asymmetric primaquine (PQ) and halogenaniline fumardiamides (-), we now report their significant in vitro activity against the hepatic stages of parasites. Furthermore, we successfully prepared chloroquine (CQ) analogue derivatives (-) and evaluated their activity against both the hepatic and erythrocytic stages of .

View Article and Find Full Text PDF

The paper is focused on the synthesis and screening of the antiplasmodial activity of novel fumardiamides 5-10 with the mefloquine pharmacophore and a Michael acceptor motif. Multi-step reactions leading to the title compounds included two amide bond formations. The first amide bond was achieved by the reaction of (E)-ethyl 4-chloro-4-oxobut-2-enoate (1) and N1-(2,8-bis(trifluoromethyl)quinolin-4-yl) butane-1,4-diamine (2).

View Article and Find Full Text PDF

Glioblastoma multiforme is one of the most aggressive brain tumors and current therapies with temozolomide or suberoylanilide hydroxamic acid (SAHA, vorinostat) show considerable limitations. SAHA is a histone deacetylase (HDAC) inhibitor that can cause undesirable side effects due to the lack of selectivity. We show here properties of a novel hybrid molecule, sahaquine, which selectively inhibits cytoplasmic HDAC6 at nanomolar concentrations without markedly suppressing class I HDACs.

View Article and Find Full Text PDF

We report the synthesis of SAHAquines and related primaquine (PQ) derivatives. SAHAquines are novel hybrid compounds that combine moieties of suberoylanilide hydroxamic acid (SAHA), an anticancer agent with weak antiplasmodial activity, and PQ, an antimalarial drug with low antiproliferative activity. The preparation of SAHAquines is simple, cheap, and high yielding.

View Article and Find Full Text PDF

Novel primaquine (PQ) and halogenaniline asymmetric fumardiamides ⁻, potential Michael acceptors, and their reduced analogues succindiamides ⁻ were prepared by simple three-step reactions: coupling reaction between PQ and mono-ethyl fumarate () or mono-methyl succinate (), hydrolysis of PQ-dicarboxylic acid mono-ester conjugates , to corresponding acids ,, and a coupling reaction with halogenanilines. 1-[bis(Dimethylamino)methylene]-1-1,2,3-triazolo[4,5-]pyridinium 3-oxide hexafluorophosphate (HATU) was used as a coupling reagent along with Hünig's base. Compounds and were evaluated against a panel of bacteria, several strains, fungi, a set of viruses, and nine different human tumor cell lines.

View Article and Find Full Text PDF